|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00149552 |
|
Date of registration:
|
06/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Zinc Therapy in HIV Infected Individuals Who Abuse Drugs
|
|
Scientific title:
|
Zinc Therapy in Zinc Deficient HIV Positive Drug Users |
|
Date of first enrolment:
|
June 2001 |
|
Target sample size:
|
231 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00149552 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Marianna K. Baum, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Florida International University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- HIV infected
- Drug User
- Blood zinc level greater than 0.35 mcg/mL and less than 0.75mcg/ml
Exclusion Criteria:
- Currently participating in an another clinical trial
- Blood selenium level less than 85 mcg/L
- Pregnant or intends to become pregnant
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
HIV Infections
|
|
Substance-Related Disorders
|
|
Intervention(s)
|
|
Dietary Supplement: zinc
|
|
Primary Outcome(s)
|
|
Immune failure
[Time Frame: For at least 6 months]
|
|
Secondary Outcome(s)
|
|
Morbidity
[Time Frame: For at least 6 months]
|
|
Secondary ID(s)
|
|
NIDA-14966-1
|
|
R01DA014966
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|